#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17080	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1985	847.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1395	1395	C	973	C	916	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31132	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3458	895.0	0	.	n	.	0	T695C	SNP	695	695	T	997	997	C	988	C,T	922,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31132	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3458	895.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1639	1639	A	978	A,C	921,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31132	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3458	895.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2273	2273	C	945	C,T	878,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31132	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3458	895.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2347	2347	A	1003	A	953	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31132	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3458	895.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2899	2899	C	937	C	895	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2018	folP	855	855	100.0	folP.l15.c4.ctg.1	1608	124.7	1	SNP	p	R229S	1	.	.	685	687	AGC	978	980	AGC	194;195;192	A;G;C	185;184;180	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5544	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3424	161.5	1	SNP	p	S91F	1	.	.	271	273	TTC	590	592	TTC	190;190;188	T;T;C	181;177;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5544	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3424	161.5	1	SNP	p	G95N	0	.	.	283	285	GGC	602	604	GGC	192;191;193	G;G;C,A	178;176;175,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5544	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3424	161.5	1	SNP	p	D95G	1	.	.	283	285	GGC	602	604	GGC	192;191;193	G;G;C,A	178;176;175,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1758	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1324	131.9	1	SNP	p	G45D	0	.	.	133	135	GGC	441	443	GGC	220;219;216	G;G;C	210;208;208	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	894	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1112	79.9	0	.	n	.	0	A197.	DEL	197	197	A	593	593	A	212	A	195	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5454	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2907	186.8	1	SNP	p	D86N	0	.	.	256	258	GAC	574	576	GAC	219;220;223	G;A;C	199;196;204	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5454	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2907	186.8	1	SNP	p	S87R	1	.	.	259	261	CGT	577	579	CGT	223;226;224	C;G;T	206;207;203	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5454	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2907	186.8	1	SNP	p	R87I	0	.	.	259	261	CGT	577	579	CGT	223;226;224	C;G;T	206;207;203	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5454	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2907	186.8	1	SNP	p	R87W	0	.	.	259	261	CGT	577	579	CGT	223;226;224	C;G;T	206;207;203	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5454	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2907	186.8	1	SNP	p	S88P	0	.	.	262	264	TCC	580	582	TCC	227;229;229	T;C;C	205;212;212	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4506	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2577	173.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	214;213;215	G;G;C	203;198;197	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1230	1232	GCA	245;243;242	G;C;A	229;230;230	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1233	1235	ATC	241;241;241	A;T;C	229;226;226	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1245	1247	GTG	245;247;249	G,C;T;G	232,1;229;232	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1245	1247	GTG	245;247;249	G,C;T;G	232,1;229;232	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1749	1751	ACC	224;224;224	A;C;C	208;208;213	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1803	1805	GCG	213;210;207	G;C;G	183;156;165	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1803	1805	GCG	213;210;207	G;C;G	183;156;165	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1926	1928	AGC	201;195;195	A;G;C	184;175;179	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1935	1937	GGC	187;186;184	G;G;C	175;172;168	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4422	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2321	189.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1953	1955	CCG	160;163;167	C,G;C;G	118,7;121;127	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6342	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3073	205.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1591	1593	CCG	217;216;215	C;C;G	187;194;184	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2294	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1785	127.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	624	624	C	160	C	142	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	402	404	GAA	282;280;281	G;A;A	269;270;272	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	0	.	p	.	0	T119A	NONSYN	355	357	ACC	645	647	GCC	275;276;273	G;C;C	252;257;260	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	690	692	GAT	272;272;275	G;A;T	255;255;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	813	815	TCA	283;283;286	T;C;A	256;259;263	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	942	944	GTC	260;259;263	G;T;C	245;247;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1272	1274	GCA	261;262;263	G;C,A;A	248;248,1;248	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	276;276;276	A;A,C;G	261;260,1;259	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	1	SNP	p	A121D	1	.	.	361	363	GAC	651	653	GAC	279;277;279	G;A;C	265;260;266	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3354	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1482	221.5	1	SNP	p	D121N	0	.	.	361	363	GAC	651	653	GAC	279;277;279	G;A;C	265;260;266	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12244	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4914	248.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1416	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1034	135.7	1	SNP	p	V57M	1	.	.	169	171	ATG	463	465	ATG	309;309;309	A;T;G	288;287;286	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
